ONIT Onity Group Inc.
Onity Group Inc., a financial services company, originates and services forward and reserve mortgage loans in the United States, the United States Virgin Islands, India, and the Philippines. The company operates through the Servicing and Originations segments. The company offers owned mortgage servicing rights and subservicing products; conventional, government-insured, and non-agency mortgage loans, as well as reverse mortgage and multi-family loans; and residential forward mortgage and small commercial mortgage loans. It also originates and purchases conventional and government-insured residential forward and reverse mortgage loans through its correspondent lending arrangements, broker relationships, and retail channels. In addition, the company engages in reinsurance business. The company offers its services under the PHH Mortgage and Liberty Reverse Mortgage brands. It serves financial institutions. The company was formerly known as Ocwen Financial Corporation and changed its name to Onity Group Inc. in June 2024. Onity Group Inc. was founded in 1988 and is headquartered in West Palm Beach, Florida.…
Industry Peers
Mortgage FinanceKey Statistics
About Onity Group (NYSE: ONIT)
›
Onity Group (NYSE: ONIT) is listed on the New York Stock Exchange, where its shares trade in USD. It belongs to the Mortgage Finance industry, part of the Financial Services sector, and reports about 3,900 employees.
The shares were at 24.61 USD on 20 November 2026, down 40.6% over 52 weeks. Its 52-week range is 24.51 USD to 54.10 USD, and it trades at the bottom of that range.
At a market capitalisation of 205.60M USD, it trades at 1.7 times trailing earnings and 3.5 times forward earnings. The median trailing P/E of its 13 largest Mortgage Finance peers is 10.6, a discount of 84% for ONIT.
Onity Group reports return on equity of 30.2%, an operating margin of 54.1% and revenue down 0.8% year over year.
Its debt exceeds its cash by 9.59B USD. Its Piotroski F-score is 5 out of 9, an average reading of its financial health. 2 analysts cover the stock, with an average rating of Buy; their mean price target of 50.00 USD is 103.2% above the current price. The next earnings report is expected on 11 February 2027.